Transgene verification and technical improvement in the establisment of transgenic miR-32 mouse line
The main challenge to be faced with prostate cancer (PCa) is the segregation and treatment of patients with life-threatening disease. As current prognostic, diagnostic and therapeutic tools are insufficient, solution is tried to be found from new biomarkers. One of these could be microRNA miR-32,...
| Päätekijä: | |
|---|---|
| Muut tekijät: | , , , , , |
| Aineistotyyppi: | Pro gradu |
| Kieli: | eng |
| Julkaistu: |
2015
|
| Aiheet: | |
| Linkit: | https://jyx.jyu.fi/handle/123456789/47395 |